Pédiatrie Neuroblastomes J1O-MC-JZHD A Phase 1 Study of;Aurora Kinase A Inhibitor LY3295668 erbumine as a Single;Agent and in Combination in Patients with;Relapsed/Refractory Neuroblastoma Paris ISABELLE AERTS